Market Moves
MintNeuro becomes Motif Neurotech's silicon supplier as the BCI supply chain splits from vertical integration
Imperial College London spinout MintNeuro announced a multi-year commercial supply agreement on 30 April 2026 to provide its miniaturised sensing and stimulation integrated circuits to Motif Neurotech's DOT depression implant across pre-clinical, early clinical, and pivotal trial phases. The deal was announced three days after Motif announced FDA approval of its Investigational Device Exemption.